real-time news and commentary for investors
Monday, Mar 4
A 2 1/2 year-old infant appears to have been cured of HIV following aggressive treatment soon...
A 2 1/2 year-old infant appears to have been cured of HIV following aggressive treatment soon after birth with the drugs lamivudine and zidovudine, which are sold by a joint venture between GlaxoSmithKline (GSK), Pfizer (PFE), ViiV Healthcare and Abbott Laboratories' (ABT) Kaletra. The news could revolutionize the way babies with HIV are treated. "It's proof of principle that we can cure HIV infection if we can replicate this case," says Johns Hopkins' Deborah Persaud, the lead author of a report on the case.